Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simon Bergqvist

Showing results (21-30 of 34) with videos related to

Pageof 4
Sort By:
Bioorganic & Medicinal Chemistry Letters|May 27, 2011
Design strategies to target crystallographic waters applied to the Hsp90 molecular chaperonePei-Pei Kung, Piet-Jan Sinnema, Paul Richardson, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 19, 2013
Covalent EGFR inhibitor analysis reveals importance of reversible interactions to potency and mechanisms of drug resistancePhillip A Schwartz, Petr Kuzmic, James Solowiej, et al.
Protein Science : a Publication of the Protein Society|October 4, 2012
Identification of Cys255 in HIF-1α as a novel site for development of covalent inhibitors of HIF-1α/ARNT PasB domain protein-protein interactionRosa Cardoso, Robert Love, Carol L Nilsson, et al.
Molecular Cancer Therapeutics|August 7, 2016
Spectrum and Degree of CDK Drug Interactions Predicts Clinical PerformancePing Chen, Nathan V Lee, Wenyue Hu, et al.
Biochemistry|September 12, 2009
Characterization of the CHK1 allosteric inhibitor binding siteDarin Vanderpool, Ted O Johnson, Chen Ping, et al.
Cancer Immunology, Immunotherapy : CII|March 13, 2012
Targeting of 4-1BB by monoclonal antibody PF-05082566 enhances T-cell function and promotes anti-tumor activityTimothy S Fisher, Cris Kamperschroer, Theodore Oliphant, et al.
Structure (London, England : 1993)|December 17, 2009
Structure of HIV-1 reverse transcriptase with the inhibitor beta-Thujaplicinol bound at the RNase H active siteDaniel M Himmel, Karen A Maegley, Tom A Pauly, et al.
Cancer Research|December 17, 2010
Dual functional monoclonal antibody PF-04605412 targets integrin alpha5beta1 and elicits potent antibody-dependent cellular cytotoxicityGang Li, Lianglin Zhang, Enhong Chen, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 5, 2010
Small-molecule p21-activated kinase inhibitor PF-3758309 is a potent inhibitor of oncogenic signaling and tumor growthBrion W Murray, Chuangxing Guo, Joseph Piraino, et al.
Oncotarget|May 2, 2019
PD-L1 checkpoint blockade delivered by retroviral replicating vector confers anti-tumor efficacy in murine tumor modelsLeah A Mitchell, Kader Yagiz, Andrew Hofacre, et al.
Pageof 4

Showing results (21-30 of 34) with videos related to

Sort By:
Pageof 4
Bioorganic & Medicinal Chemistry Letters|May 27, 2011
Design strategies to target crystallographic waters applied to the Hsp90 molecular chaperonePei-Pei Kung, Piet-Jan Sinnema, Paul Richardson, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 19, 2013
Covalent EGFR inhibitor analysis reveals importance of reversible interactions to potency and mechanisms of drug resistancePhillip A Schwartz, Petr Kuzmic, James Solowiej, et al.
Protein Science : a Publication of the Protein Society|October 4, 2012
Identification of Cys255 in HIF-1α as a novel site for development of covalent inhibitors of HIF-1α/ARNT PasB domain protein-protein interactionRosa Cardoso, Robert Love, Carol L Nilsson, et al.
Molecular Cancer Therapeutics|August 7, 2016
Spectrum and Degree of CDK Drug Interactions Predicts Clinical PerformancePing Chen, Nathan V Lee, Wenyue Hu, et al.
Biochemistry|September 12, 2009
Characterization of the CHK1 allosteric inhibitor binding siteDarin Vanderpool, Ted O Johnson, Chen Ping, et al.
Cancer Immunology, Immunotherapy : CII|March 13, 2012
Targeting of 4-1BB by monoclonal antibody PF-05082566 enhances T-cell function and promotes anti-tumor activityTimothy S Fisher, Cris Kamperschroer, Theodore Oliphant, et al.
Structure (London, England : 1993)|December 17, 2009
Structure of HIV-1 reverse transcriptase with the inhibitor beta-Thujaplicinol bound at the RNase H active siteDaniel M Himmel, Karen A Maegley, Tom A Pauly, et al.
Cancer Research|December 17, 2010
Dual functional monoclonal antibody PF-04605412 targets integrin alpha5beta1 and elicits potent antibody-dependent cellular cytotoxicityGang Li, Lianglin Zhang, Enhong Chen, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 5, 2010
Small-molecule p21-activated kinase inhibitor PF-3758309 is a potent inhibitor of oncogenic signaling and tumor growthBrion W Murray, Chuangxing Guo, Joseph Piraino, et al.
Oncotarget|May 2, 2019
PD-L1 checkpoint blockade delivered by retroviral replicating vector confers anti-tumor efficacy in murine tumor modelsLeah A Mitchell, Kader Yagiz, Andrew Hofacre, et al.
Pageof 4